Compare RGNX & FWRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGNX | FWRD |
|---|---|---|
| Founded | 2008 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.1M | 512.4M |
| IPO Year | 2015 | 2024 |
| Metric | RGNX | FWRD |
|---|---|---|
| Price | $9.30 | $19.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $28.75 | ★ $38.50 |
| AVG Volume (30 Days) | ★ 570.9K | 528.0K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.08 | ★ 88.54 |
| EPS | N/A | ★ N/A |
| Revenue | $10,393,000.00 | ★ $1,269,573,000.00 |
| Revenue This Year | $50.15 | $6.57 |
| Revenue Next Year | $23.42 | $6.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.85 | $14.15 |
| 52 Week High | $16.19 | $32.47 |
| Indicator | RGNX | FWRD |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 51.50 |
| Support Level | $7.76 | $17.41 |
| Resistance Level | $10.08 | $23.20 |
| Average True Range (ATR) | 0.51 | 0.77 |
| MACD | 0.16 | 0.66 |
| Stochastic Oscillator | 95.65 | 87.96 |
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in North and South America, Europe, and Asia.